Table 2 Trial characteristics
Number | Percent | |
|---|---|---|
Disease Settings | ||
1 | 5 | 2.3 |
2 | 96 | 44.4 |
3 | 115 | 53.2 |
Systemic Therapy as Investigative Intervention | ||
0 | 19 | 8.8 |
1 | 95 | 44.0 |
2 | 84 | 38.9 |
3 | 17 | 7.9 |
4 | 1 | 0.5 |
Radiotherapy as Investigative Intervention | ||
Not Used | 121 | 56.0 |
Part of Standard Protocol | 75 | 34.7 |
Experimental | 20 | 9.3 |
Imaging as Investigative Intervention | ||
Not Mentioneda | 206 | 95.4 |
Experimental | 10 | 4.6 |
Surgery as Investigative Intervention | ||
Not Used | 134 | 62.0 |
Part of Standard Protocol | 71 | 32.9 |
Experimental | 11 | 5.1 |
Trial Overall Status | ||
Completed | 93 | 43.1 |
Active, not recruiting | 52 | 24.1 |
Not yet recruiting | 13 | 6.0 |
Recruiting | 58 | 26.9 |
Primary Sponsor Type | ||
Industry | 56 | 25.9 |
NIH | 20 | 9.3 |
academy | 123 | 56.9 |
collaborative group | 17 | 7.9 |
Date of Registration | ||
2005–2009 | 101 | 46.8 |
2010–2015 | 115 | 53.2 |